Piflufolastat (18F) enters commercial market in Spain
Piflufolastat (18F) is being produced at 2 Curium facilities in Madrid and 1 in Sevilla.
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
In this episode of Speaking of Urology®, Ashley G. Winter, MD, discusses the use of vaginal estrogen.
FDA Advisory Committee meets to discuss NDA of oral sulopenem for uUTI
Follow Urology Times' coverage of the full-day FDA advisory committee meeting regarding Iterum Therapeutics' new drug application for oral sulopenem for uncomplicated urinary tract infection.
Health policy in urology: 2024 AUA Advocacy Summit recap
In this episode of Speaking of Urology®, Eugene Rhee, MD, MBA, and Logan Galansky, MD, discuss key topics in health policy and recap the AUA's recent Annual Urology Advocacy Summit.
Collaboration to advance market launch of ProVate device for pelvic organ prolapse
The company expects the device to become available for US patients with pelvic organ prolapse in September 2024.
ACS launches National Prostate Cancer Roundtable to address increasing incidence
"The urgency to increase awareness about prostate cancer is underscored by our most recent data and analysis," says William L. Dahut, MD.
